perimenopause and glp 1 PSA for all the women on GLP-1s hormone replacement therapy (HRT Perimenopause And GLP-1 Weight Loss
Description
This leads to reduced calorie intake and significant weight loss
Zepbound is made by drugmaker Eli Lilly
It is not appropriate for patients with BMI over 40 or significant cardiovascular risk
For patients first prescribed an ADM in June 2025, 72.2% filled a GLP-1 RA within 60 days
doi: 10.1210/endo.139.11.6295
doi: 10.1016/j.semnephrol.2008.01.009
